The new type 2 diabetes treatment algorithm consensus statement from the American Association of Clinical Endocrinologists (AACE), running to 48 pages, has been published online and is available for ...

DelveInsight’s, “Diabetes - Pipeline Insight, 2025” report provides comprehensive insights about 200+ companies and 200+ pipeline drugs in Diabetes pipeline landscape. It covers the pipeline drug ...

Successful treatment makes all the difference to long-term health, and achieving balanced diabetes treatment can be the key to living with both type 1 and type 2 diabetes Treatment varies for each ...

The evaluation committee considered evidence submitted by Eli Lilly, a review of this submission by the external assessment group (EAG), and response from the company. See the committee papers for ...

Tirzepatide, also known as Mounjaro and developed by Eli Lilly, has been recommended in final draft guidance issued by NICE today (Friday 8 September 2023) for treating poorly controlled type 2 ...

Tandem Diabetes Care has secured a new FDA clearance for its insulin dose-calculating algorithm, opening up its use to adults with Type 2 diabetes. The Control-IQ+ program—now with the added ...

Type 2 diabetes mellitus is a metabolic disorder that results in hyperglycemia (high blood glucose levels) due to the body: Being ineffective at using the insulin it has produced; also known as ...

Millions of people with type 2 diabetes could receive better treatment thanks to a new, simple low-cost tool, according to groundbreaking research announced today at the Diabetes UK Professional ...

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...